32
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Polymorphism of Rifampicin in FDCs: Correlation With in vitro Dissolution Test

, &
Pages 53-70 | Published online: 10 Oct 2008
 

Abstract

The use of fixed dose combinations (FDCs) of anti-TB (Tuberculosis) drugs is recommended by World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) to ensure proper treatment of tuberculosis. FDCs have the advantage of simplifying the prescription of drugs and the management of drug supply and may also limit the risk of drug resistant TB arising as a result of inappropriate drug selection and monotherapy. But the major problem with the use of FDCs is the poor/variable bioavailability of rifampicin. In the present work, the physical form of rifampicin in various marketed anti-TB formulations was identified with the help of solid-state characterization techniques. As rifampicin shows pH dependent solubility, dissolution studies of the same FDCs were conducted in three dissolution media having differing pH values. Results indicated that there was no correlation between the rifampicin polymorphic form present in the formulations and the drug release from the same. Powder dissolution and particle size analysis studies also indicated that the principle factor affecting dissolution of rifampicin form I and form II is the particle size and not the energy differences.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.